Century Therapeutics, Inc. Profile Avatar - Palmy Investing

Century Therapeutics, Inc.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent s…

Biotechnology
US, Philadelphia [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of IPSC's Analysis
CIK: 1850119 CUSIP: 15673T100 ISIN: US15673T1007 LEI: - UEI: -
Secondary Listings
IPSC has no secondary listings inside our databases.